TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
BDX

Becton Dickinson and Company

Healthcare · Medical Instruments & Supplies

181.40$ -0.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Becton Dickinson and Company (BDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 4,983 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BDX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
5,087 4,706 5,045 4,990 5,437 5,168 5,272 5,509 5,890 5,252 4,714 4,983 20,839
3,386 2,679 2,741 2,683 2,950 2,933 3,015 2,875 3,092 2,908 2,560 2,668 11,228
1,701 2,027 2,304 2,307 2,487 2,235 2,257 2,634 2,798 2,344 2,154 2,315 9,611
281 290 299 299 302 343 302 297 322 318 249 258 1,147
1,137 1,213 1,193 1,196 1,256 1,318 1,273 1,320 1,366 1,432 1,213 1,261 5,272
1,352 1,588 1,570 1,705 1,865 1,782 1,711 1,752 2,102 1,750 2,061 1,652 7,565
349 439 734 602 622 453 546 882 697 594 94 663 2,048
113 111 125 137 155 155 151 152 155 107 149 132 543
181 359 633 500 514 306 363 703 510 487 39 554 1,590
27 77 96 13 114 3.0 55 129 17 105 76 103 301
108 281 537 487 400 303 308 574 493 382 -311 377 941
881 1,031 1,329 1,205 1,255 1,068 1,122 1,473 1,294 1,208 709 686 3,897

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?